Advisory Council for the Elimination of Tuberculosis Meeting, 49609 [2017-23335]
Download as PDF
<![CDATA[
ethrower on DSK3G9T082PROD with NOTICES
Federal Register / Vol. 82, No. 206 / Thursday, October 26, 2017 / Notices
public comment period for the proposal
by 30 days, so that the comment period
ends on November 23, 2017.
DATES: The proposed collection of
information is amended effective
October 18, 2017 and the public
comment period shall terminate on
November 23, 2017.
FOR FURTHER INFORMATION CONTACT: A
copy of the PRA OMB submission,
including the proposed reporting form
and instructions, supporting statement,
and other documentation will be placed
into OMB’s public docket files, once
approved. These documents will also be
made available on the Board’s public
Web site at: https://
www.federalreserve.gov/apps/
reportforms/review.aspx or may be
requested from the agency clearance
officer, whose name appears below.
Federal Reserve Board Clearance
Officer—Nuha Elmaghrabi—Office of
the Chief Data Officer, Board of
Governors of the Federal Reserve
System, Washington, DC 20551, (202)
452–3829. Telecommunications Device
for the Deaf (TDD) users may contact
(202) 263–4869, Board of Governors of
the Federal Reserve System,
Washington, DC 20551.
SUPPLEMENTARY INFORMATION: On August
24, 2017, the Board invited public
comment on a proposal that would
extend for three years the FR Y–15 and
make certain revisions to the report (FR
Y–15 proposal). As revised, the report
would include Mexican pesos in total
payments activity rather than as a
memorandum item; add securities
brokers to the definition of financial
institutions; expressly include
derivative transactions where a clearing
member bank guarantees the
performance of a client to a central
counterparty; and, specify how certain
cleared derivatives transactions are
reported.1 As initially proposed, these
revisions to the FR Y–15 would have
been effective for reports reflecting a
December 31, 2017, as-of date. The
comment period for the FR Y–15
proposal was previously scheduled to
end on October 23, 2017.
The Board has received feedback that
additional time may be required for
affected banking organizations to
analyze the impact of, and to provide
comments on, the FR Y–15 changes
being proposed.
In response to the feedback, this
notice hereby reopens the public
comment period for the FR Y–15
proposal by 30 days, with comments
due November 23, 2017, to provide
additional time for comment.
1 See
82 FR 40154 (August 24, 2017).
VerDate Sep<11>2014
17:29 Oct 25, 2017
Jkt 244001
This notice also amends the proposed
implementation date of the FR Y–15
proposal such that the proposed
changes would be effective for reports
reflecting the March 31, 2018, as-of date.
This revision would provide
respondents with an additional 90 days
to prepare their systems to reflect any
changes to the FR Y–15 that the Board
may adopt after reviewing the
comments received.
Board of Governors of the Federal Reserve
System, October 23, 2017.
Ann E. Misback,
Secretary of the Board.
[FR Doc. 2017–23271 Filed 10–25–17; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Advisory
Council for the Elimination of
Tuberculosis (ACET). This meeting is
open to the public, limited only by 100
room seating and 100 ports for audio
phone lines. Time will be available for
public comment. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is Monday,
December 4, 2017. Persons who desire
to make an oral statement, may request
it at the time of the public comment
period on December 12, 2017 at 11:40
a.m. EST. This meeting is also
accessible by teleconference: 1–877–
927–1433 and participant passcode:
12016435.
DATES: The meeting will be held on
December 11, 2017, 8:30 a.m. to 4:30
p.m., EST and December 12, 2017, 8:30
a.m. to 12:00 p.m., EST.
ADDRESSES: CDC Corporate Square
Campus, 8 Corporate Square Boulevard,
Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road NE., Mailstop: E–07,
Atlanta, Georgia 30329, telephone (404)
639–8317; zkr7@cdc.gov.
SUMMARY:
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
49609
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters To Be Considered: The agenda
will include discussions on (1) Update
on preliminary tuberculosis funding
formula; (2) Update on whole genome
sequencing data sharing plan; (3)
Update on three-month Isoniazid/
Rifapentine Regimen (3HP) guidelines;
and (4) Updates from ACET
workgroups. Agenda items are subject to
change as priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–23335 Filed 10–25–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting for the Board of
Scientific Counselors, Office of
Infectious Diseases (BSC, OID). This
meeting is open to the public, limited
only by the space available; the meeting
room will accommodate up to 100
people. The public is also welcome to
listen to the meeting by telephone,
limited only by the number of ports
SUMMARY:
E:\FR\FM\26OCN1.SGM
26OCN1
]]>Agencies
[Federal Register Volume 82, Number 206 (Thursday, October 26, 2017)]
[Notices]
[Page 49609]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23335]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Council for the Elimination of
Tuberculosis (ACET). This meeting is open to the public, limited only
by 100 room seating and 100 ports for audio phone lines. Time will be
available for public comment. Comments should be submitted in writing
by email to the contact person listed below. The deadline for receipt
is Monday, December 4, 2017. Persons who desire to make an oral
statement, may request it at the time of the public comment period on
December 12, 2017 at 11:40 a.m. EST. This meeting is also accessible by
teleconference: 1-877-927-1433 and participant passcode: 12016435.
DATES: The meeting will be held on December 11, 2017, 8:30 a.m. to 4:30
p.m., EST and December 12, 2017, 8:30 a.m. to 12:00 p.m., EST.
ADDRESSES: CDC Corporate Square Campus, 8 Corporate Square Boulevard,
Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600 Clifton Road NE., Mailstop: E-07,
Atlanta, Georgia 30329, telephone (404) 639-8317; [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations regarding
policies, strategies, objectives, and priorities; addresses the
development and application of new technologies; and reviews the extent
to which progress has been made toward eliminating tuberculosis.
Matters To Be Considered: The agenda will include discussions on
(1) Update on preliminary tuberculosis funding formula; (2) Update on
whole genome sequencing data sharing plan; (3) Update on three-month
Isoniazid/Rifapentine Regimen (3HP) guidelines; and (4) Updates from
ACET workgroups. Agenda items are subject to change as priorities
dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2017-23335 Filed 10-25-17; 8:45 am]
BILLING CODE 4163-18-P
